StockData
Alpha Cognition Inc. logo

Alpha Cognition Inc. (ACOG) stock

ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3060% above fair value
$7.83−0.47 (-5.66%)

Close on Nov 16, 2026Market cap $170.52MP/E –Yield –

Alpha Cognition cash

Cash and short-term investments held at the end of each period.

Alpha Cognition's cash was $41.38M at Jun 30, 2026. For fiscal 2025 it was $66.05M, up 36.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$66.05M+36.0%
FY2024Dec 31, 2024$48.56M+3149.4%
FY2023Dec 31, 2023$1.49M-28.3%
FY2022Dec 31, 2022$2.08M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$41.38M+4.9%
Q1 FY2026Mar 31, 2026$54.25M+18.9%
Q4 FY2025Dec 31, 2025$66.05M+36.0%
Q3 FY2025Sep 30, 2025$35.40M+838.1%
Q2 FY2025Jun 30, 2025$39.46M+3204.7%
Q1 FY2025Mar 31, 2025$45.62M+1782.8%
Q4 FY2024Dec 31, 2024$48.56M+3149.4%
Q3 FY2024Sep 30, 2024$3.77M+315.4%
Q2 FY2024Jun 30, 2024$1.19M-1.9%
Q1 FY2024Mar 31, 2024$2.42M+16.3%
Q4 FY2023Dec 31, 2023$1.49M–
Q3 FY2023Sep 30, 2023$908.36K–
Q2 FY2023Jun 30, 2023$1.22M–
Q4 FY2022Dec 31, 2022$2.08M–

More Alpha Cognition figures

See a number that looks wrong?